海创药业:2025年营业收入2067.38万元,同比增加2030.7万元

Group 1 - The company announced a revenue of 20.67 million yuan for the year 2025, an increase of 20.31 million yuan year-on-year [1] - The net profit attributable to the parent company's owners was -137 million yuan, a reduction in losses of 62.81 million yuan year-on-year [1] - The net profit attributable to the parent company's owners, excluding non-recurring gains and losses, was -167 million yuan, a reduction in losses of 50.14 million yuan year-on-year [1]

Hinova Pharmaceuticals -海创药业:2025年营业收入2067.38万元,同比增加2030.7万元 - Reportify